查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080370

電腦斷層掃描（CT）市場：按產品類型、組件、應用、最終用戶和模式分類的全球市場預測，2026-2032年

Computed Tomography Market by Product Type, Component, Application, End User, Modality - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，電腦斷層掃描 (CT) 市場將成長至 121.7 億美元，複合年成長率為 6.45%。

主要市場統計數據
基準年 2025 78.6億美元
預計年份：2026年 83.2億美元
預測年份 2032 121.7億美元
複合年成長率 (%) 6.45%

電腦斷層掃描（CT）仍然是急診醫學、腫瘤學、循環系統、神經病學、呼吸醫學和影像引導介入治療中最具戰略意義的醫學影像技術之一，能夠提供快速、高解析度的截面影像。醫院和影像中心利用CT掃描儀對創傷、中風、肺動脈栓塞、冠狀動脈疾病、癌症分期和治療後後續觀察等情況進行時間敏感型診斷。

CT市場趨勢受臨床需求驅動，這些需求包括提高處理速度、降低輻射暴露、改善影像品質以及確保診斷的可靠性。人口老化、全球非傳染性疾病負擔日益加重以及成熟和新興醫療體系中先進影像基礎設施的持續擴張，都是推動市場需求成長的因素。

除了人工智慧驅動的重建和工作流程自動化之外，創新也日益聚焦於低劑量CT、頻譜CT、雙能量CT、寬檢測器系統、可攜式CT和光子計數CT。對於產業領導者而言，CT不再只是一種硬體類別，而是涵蓋掃描器、檢測器、軟體、服務合約、雲端連接、網路安全和臨床決策支援的整合生態系統。

CT產業的變革

CT產業正在經歷一場結構性變革，從設備更換模式轉向數位化連接、協議主導的成像平台。醫療機構優先考慮能夠縮短掃描時間、實現影像擷取標準化、支援企業級影像整合並提高放射科營運效率的系統。

人工智慧在康乃狄克州的累積影響

人工智慧 (AI) 在 CT 影像診斷的整個過程中累積創造價值，從患者定位和掃描方案選擇到影像重建、分診、分割、量化和結構化報告產生。 AI 驅動的重建技術能夠在保持影像品質的同時實現低劑量掃描，而 AI 分診工具則有助於識別顱內出血、肺動脈栓塞、氣胸和大血管閉塞等緊急觀察。

關於電腦斷層掃描（CT）的關鍵區域見解

亞太地區是CT市場最具活力的地區之一，這得益於龐大的患者群體、不斷擴展的醫院網路以及對診斷基礎設施日益成長的投資。中國、印度、日本、韓國和澳洲是該地區需求的核心，其中日本和韓國高階CT系統的應用日益普及，而中國和印度則因公立和私立醫療機構的檢查量巨大而呈現出強勁的需求。

主要經濟區各群體的關鍵趨勢

東協地區的需求主要受新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國醫院擴建、醫療旅遊以及慢性病診斷率上升的驅動。該地區市場結構呈現兩極化：一方面，先進的都市區醫院採用高階CT系統；另一方面，更廣泛的醫療保健網路則需要經濟高效、性能可靠且具備全面服務支援和技術人員培訓的平台。

主要國家電腦斷層掃描（CT）的關鍵趨勢

美國在先進CT技術的應用方面仍然主導，這得益於其高診斷成像利用率、完善的門診成像網路、對急診醫療服務的需求以及人工智慧放射診斷工具的快速商業化。加拿大的CT發展格局則受到公共醫療保健優先事項、候診時間管理、品質標準以及對尖端診斷能力投資的影響。另一方面，墨西哥則受益於私立醫院的擴張、都市區診斷需求的成長以及跨境醫療保健需求。

為行業領導者提供的實用建議

產業領導者應優先考慮兼具影像品質、劑量效率、工作流程自動化和可衡量的經濟價值的CT平台。採購決策越來越依賴整體擁有成本、運轉率、服務應對力、網路安全、能源效率以及與企業成像生態系統的兼容性。

調查方法

本執行摘要基於一套系統的調查方法，該方法結合了二手資料研究、資料檢驗和專家解讀。資訊來源衛生當局、監管機構、同行評審文獻、醫院採購趨勢、臨床指南制定機構的信息，以及來自世界衛生組織、經濟合作暨發展組織、美國食品藥品監督管理局、歐盟委員會等國際組織和各國衛生機構的公開資訊。

結論

電腦斷層掃描（CT）正步入一個新階段，其特點是智慧成像、輻射防護、更有效率的工作流程以及一體化的診斷生態系統。這項需求源自於全球疾病負擔的加重，包括癌症、心血管疾病、神經系統急症、創傷和慢性呼吸系統疾病，所有這些都需要及時、準確的影像診斷。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 電腦斷層掃描（CT）市場：依產品類型分類

  • 多切面
    • 16片
    • 64片
    • 64片或更多
  • 單切片

第8章 電腦斷層掃描（CT）市場：依組件分類

  • 硬體
  • 服務
  • 軟體

第9章 電腦斷層掃描（CT）市場：依應用領域分類

  • 循環系統
    • 鈣化評分
    • 心臟結構評估
    • 冠狀動脈CT血管攝影檢查（CTA）
  • 胃腸病學
  • 神經病學
    • 腦灌注檢查
    • 腦腫瘤的評估
    • 顱骨骨折
    • 中風評估
  • 腫瘤學
    • 切片檢查引導
    • 疾病分期
    • 治療監測
    • 腫瘤檢測
  • 整形外科
  • 創傷

第10章 電腦斷層掃描（CT）市場：依最終使用者分類

  • 門診手術中心
  • 診所
  • 診斷影像中心
  • 醫院

第11章 電腦斷層掃描（CT）市場：依模式分類

  • 固定式
  • 可攜式的

第12章 電腦斷層掃描（CT）市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 電腦斷層掃描（CT）市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 電腦斷層掃描（CT）市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Allengers Medical Systems Ltd.
  • Arineta Ltd.
  • Basda Medical Apparatus Co., Ltd.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Izotropic Corporation
  • J. Morita Corporation
  • Koning Corporation
  • Koninklijke Philips NV
  • MARS Bioimaging Ltd.
  • MinFound Medical Systems Co., Ltd.
  • MR Solutions Ltd.
  • NeuroLogica Corp.
  • Neusoft Medical Systems Co., Ltd.
  • Planmeca Oy
  • Shenzhen Anke High-tech Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Trivitron Healthcare
  • United Imaging Healthcare Co., Ltd.
  • Vatech Co., Ltd.
  • Xoran Technologies, Inc.
Product Code: MRR-434CCDA04E9D

The Computed Tomography Market is projected to grow by USD 12.17 billion at a CAGR of 6.45% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.86 billion
Estimated Year [2026] USD 8.32 billion
Forecast Year [2032] USD 12.17 billion
CAGR (%) 6.45%

Computed tomography (CT) remains one of the most strategically important medical imaging modalities because it delivers rapid, high-resolution cross-sectional visualization for emergency medicine, oncology, cardiology, neurology, pulmonology, and image-guided interventions. Hospitals and imaging centers rely on CT scanners for time-sensitive diagnosis in trauma, stroke, pulmonary embolism, coronary artery disease, cancer staging, and post-treatment surveillance.

The computed tomography landscape is being shaped by the clinical need for faster throughput, lower radiation dose, improved image quality, and consistent diagnostic confidence. Demand is reinforced by aging populations, the rising global burden of noncommunicable diseases, and the continued expansion of advanced diagnostic imaging infrastructure across mature and emerging healthcare systems.

Innovation is increasingly centered on low-dose CT, spectral CT, dual-energy CT, wide-detector systems, portable CT, and photon-counting CT, alongside artificial intelligence-enabled reconstruction and workflow automation. For industry leaders, CT is no longer only a hardware category; it is an integrated ecosystem spanning scanners, detectors, software, service contracts, cloud connectivity, cybersecurity, and clinical decision support.

Transformative Shifts in the CT Landscape

The CT landscape is undergoing a structural shift from equipment replacement cycles toward digitally connected, protocol-driven imaging platforms. Healthcare providers are prioritizing systems that reduce scan time, standardize image acquisition, support enterprise imaging integration, and improve operational productivity across radiology departments.

A major transformation is the movement toward patient-centered and value-based imaging. Providers are under pressure to improve diagnostic yield while managing radiation exposure, staffing shortages, reimbursement scrutiny, and rising procedure volumes. This is accelerating adoption of dose-optimization tools, automated positioning, iterative and deep learning reconstruction, and standardized reporting workflows.

Another important shift is the diversification of CT use sites. While tertiary hospitals remain central to advanced applications such as cardiac CT, oncology staging, and stroke imaging, outpatient imaging networks and ambulatory care centers are expanding access to routine CT examinations. At the same time, sustainability, energy efficiency, uptime guarantees, lifecycle service models, and secure connectivity are becoming decisive procurement factors.

Cumulative Impact of Artificial Intelligence on CT

Artificial intelligence is creating cumulative value across the CT imaging chain, from patient positioning and protocol selection to image reconstruction, triage, segmentation, quantification, and structured reporting. AI-enabled reconstruction can support lower-dose scanning while preserving image quality, and AI triage tools can help flag urgent findings such as intracranial hemorrhage, pulmonary embolism, pneumothorax, and large vessel occlusion.

Regulatory momentum supports the long-term role of AI in CT. The U.S. FDA has authorized hundreds of AI-enabled medical devices across imaging and radiology, demonstrating that software is becoming a core differentiator for diagnostic platforms. However, real-world adoption depends on validated performance, clinical workflow fit, interoperability with PACS, RIS, and electronic health records, transparent governance, and continuous monitoring for bias and model drift.

The cumulative impact of AI is strongest where it improves measurable outcomes: reduced turnaround time, fewer repeat scans, improved radiologist productivity, lower radiation exposure, and more consistent quantitative assessment in oncology, cardiology, and lung disease. Vendors that combine CT hardware innovation with secure, explainable, and clinically validated AI are better positioned in competitive procurement cycles.

Key Regional Insights for Computed Tomography

Asia-Pacific is one of the most dynamic CT regions, supported by large patient populations, expanding hospital networks, and growing investment in diagnostic infrastructure. China, India, Japan, South Korea, and Australia are central to regional demand, with Japan and South Korea demonstrating advanced adoption of high-end CT systems and China and India showing strong volume-led demand across public and private care settings.

North America remains a technology-leading region, driven by high imaging utilization, a broad installed base, advanced clinical protocols, and early adoption of AI-enabled imaging. The United States anchors regional demand through extensive hospital networks, outpatient imaging centers, and regulatory pathways that support advanced CT and imaging software commercialization, while Canada emphasizes access, quality, public procurement, and modernization of diagnostic capacity.

Latin America shows growing CT demand as Brazil and Mexico expand diagnostic capacity and private healthcare investment. The region faces budget constraints and uneven access, but demand is supported by urban hospital modernization, oncology care expansion, and the need for emergency imaging. Europe remains a mature and regulation-driven region, with Germany, France, Italy, Spain, and the United Kingdom emphasizing quality standards, dose management, sustainability, interoperability, and compliance with medical device regulations.

The Middle East is investing in advanced imaging as part of healthcare modernization strategies, especially across Gulf countries where specialty hospitals, trauma care, oncology programs, and medical tourism initiatives support premium CT adoption. Africa remains underpenetrated compared with other regions, but long-term opportunities are tied to public health investment, donor-supported infrastructure, urban hospital development, workforce training, and scalable service models that address maintenance and affordability.

Key Group Insights Across Major Economic Blocs

ASEAN demand is supported by hospital expansion, medical tourism, and rising chronic disease diagnosis across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The group presents a dual-market structure, with advanced urban hospitals adopting premium CT systems while broader healthcare networks require cost-effective, reliable platforms with strong service support and technologist training.

The GCC is a high-investment healthcare group where Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman are expanding specialty care, trauma services, oncology programs, and digital health infrastructure. CT procurement in the GCC is closely linked to national healthcare transformation plans, private hospital growth, medical tourism, and demand for premium imaging technologies that support rapid diagnosis and integrated care pathways.

The European Union is shaped by harmonized regulatory expectations, radiation safety principles, public procurement discipline, and strong emphasis on interoperability, cybersecurity, and sustainability. EU healthcare systems continue to invest in CT modernization, but purchasing decisions are influenced by lifecycle cost, dose optimization, compliance with evolving medical device and data protection frameworks, and the need to improve diagnostic access.

BRICS countries represent scale-driven CT opportunities, led by China and India and supported by Brazil, Russia, and South Africa. These markets combine large disease burdens with uneven imaging access, creating demand for both high-end tertiary systems and value-oriented scanners. G7 countries remain critical for innovation, clinical validation, and premium adoption because they combine advanced healthcare infrastructure with strong research institutions. NATO countries, particularly in North America and Europe, also prioritize resilient healthcare infrastructure, emergency readiness, secure medical technology supply chains, and interoperable digital systems.

Key Country Insights in Computed Tomography

The United States remains a leading country for advanced CT adoption, supported by high imaging utilization, outpatient imaging networks, emergency medicine demand, and rapid commercialization of AI-enabled radiology tools. Canada's CT environment is shaped by public healthcare priorities, wait-time management, quality standards, and investments in modern imaging capacity, while Mexico benefits from private hospital expansion, urban diagnostic growth, and cross-border healthcare demand.

Brazil leads Latin American CT activity through its large hospital base, oncology needs, and private healthcare sector, while the United Kingdom emphasizes imaging access, National Health Service capacity planning, and diagnostic center expansion. Germany remains a European imaging powerhouse with strong hospital infrastructure and demand for premium CT systems. France prioritizes quality, radiation protection, and national imaging modernization, while Italy and Spain continue to invest in equipment renewal, oncology imaging, emergency care, and regional healthcare upgrades.

Russia maintains demand for CT across large public healthcare networks and regional hospital systems, although procurement dynamics are influenced by economic and supply-chain conditions. China is a scale leader, combining domestic manufacturing capacity, public hospital investment, and rapid adoption of advanced imaging in major cities. India shows strong potential due to expanding private diagnostics, medical tourism, and rising chronic disease detection, although affordability, access, and workforce availability remain important constraints.

Japan is a mature, high-utilization CT environment with strong adoption of advanced scanner configurations and an aging population that supports sustained diagnostic demand. Australia emphasizes quality, access, and advanced imaging across public and private systems, while South Korea stands out for technologically advanced hospitals, strong digital health adoption, and a competitive private medical sector.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize CT platforms that combine image quality, dose efficiency, and workflow automation with measurable economic value. Procurement decisions increasingly depend on total cost of ownership, uptime, service responsiveness, cybersecurity, energy efficiency, and compatibility with enterprise imaging ecosystems.

Vendors should invest in clinically validated AI that solves operational pain points rather than adding disconnected features. High-impact areas include automated protocoling, low-dose reconstruction, urgent finding triage, lesion measurement, cardiac analysis, lung nodule assessment, and structured reporting. Clear evidence on productivity gains, diagnostic accuracy, and patient safety is essential for adoption.

Healthcare providers should standardize CT protocols, monitor radiation dose, train technologists on advanced capabilities, and integrate CT data into multidisciplinary care pathways. Market participants should develop differentiated strategies for mature and emerging regions, balancing premium innovation with affordable systems, financing models, remote service, preventive maintenance, and local training.

Research Methodology

This executive summary is developed using a structured research methodology that combines secondary research, data triangulation, and expert interpretation. Inputs include publicly available information from health authorities, regulatory agencies, peer-reviewed literature, hospital procurement trends, clinical guideline bodies, and international organizations such as WHO, OECD, FDA, European Commission sources, and national health agencies.

The analysis evaluates CT demand drivers, technology trends, regional adoption patterns, regulatory influences, and competitive positioning without relying on market sizing, share estimates, or forecasts. Findings are validated through cross-comparison of multiple credible sources to avoid reliance on isolated claims. Emphasis is placed on verifiable signals such as disease burden, imaging utilization, healthcare infrastructure investment, AI device authorization trends, installed-base modernization, and replacement demand.

The methodology is designed to support executive decision-making by connecting clinical need, technology innovation, reimbursement pressure, regulatory requirements, and regional readiness. Qualitative insights are interpreted through the lens of practical commercial relevance for manufacturers, software developers, healthcare providers, investors, and channel partners.

Conclusion

Computed tomography is entering a new phase defined by intelligent imaging, dose-conscious care, faster workflows, and integrated diagnostic ecosystems. Demand is supported by the global burden of cancer, cardiovascular disease, neurological emergencies, trauma, and chronic respiratory conditions, all of which require timely and accurate imaging.

The most competitive CT strategies align hardware innovation with AI, service reliability, interoperability, cybersecurity, and region-specific affordability. Mature regions reward premium performance, automation, and enterprise integration, while emerging regions require scalable, durable, and cost-effective CT solutions supported by training and reliable service infrastructure.

As healthcare systems pursue earlier diagnosis and more efficient care delivery, CT remains central to modern medical imaging. Organizations that demonstrate clinical value, operational efficiency, radiation safety, and trusted technology governance are best positioned to build resilient long-term advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Computed Tomography Market, by Product Type

  • 7.1. Multi Slice
    • 7.1.1. 16 Slices
    • 7.1.2. 64 Slices
    • 7.1.3. Above 64 Slices
  • 7.2. Single Slice

8. Computed Tomography Market, by Component

  • 8.1. Hardware
  • 8.2. Services
  • 8.3. Software

9. Computed Tomography Market, by Application

  • 9.1. Cardiology
    • 9.1.1. Calcium Scoring
    • 9.1.2. Cardiac Structure Assessment
    • 9.1.3. Coronary CT Angiography (CTA)
  • 9.2. Gastroenterology
  • 9.3. Neurology
    • 9.3.1. Brain perfusion Studies
    • 9.3.2. Brain Tumor Assessment
    • 9.3.3. Skull Fractures
    • 9.3.4. Stroke Evaluation
  • 9.4. Oncology
    • 9.4.1. Biopsy Guidance
    • 9.4.2. Staging
    • 9.4.3. Treatment Monitoring
    • 9.4.4. Tumor Detection
  • 9.5. Orthopedics
  • 9.6. Trauma

10. Computed Tomography Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals

11. Computed Tomography Market, by Modality

  • 11.1. Stationary
  • 11.2. Portable

12. Computed Tomography Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Computed Tomography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Computed Tomography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Allengers Medical Systems Ltd.
  • 16.2. Arineta Ltd.
  • 16.3. Basda Medical Apparatus Co., Ltd.
  • 16.4. Bruker Corporation
  • 16.5. Canon Medical Systems Corporation
  • 16.6. Carestream Health, Inc.
  • 16.7. Fujifilm Holdings Corporation
  • 16.8. GE HealthCare Technologies Inc.
  • 16.9. Hologic, Inc.
  • 16.10. Izotropic Corporation
  • 16.11. J. Morita Corporation
  • 16.12. Koning Corporation
  • 16.13. Koninklijke Philips N.V.
  • 16.14. MARS Bioimaging Ltd.
  • 16.15. MinFound Medical Systems Co., Ltd.
  • 16.16. MR Solutions Ltd.
  • 16.17. NeuroLogica Corp.
  • 16.18. Neusoft Medical Systems Co., Ltd.
  • 16.19. Planmeca Oy
  • 16.20. Shenzhen Anke High-tech Co., Ltd.
  • 16.21. Shimadzu Corporation
  • 16.22. Siemens Healthineers AG
  • 16.23. Trivitron Healthcare
  • 16.24. United Imaging Healthcare Co., Ltd.
  • 16.25. Vatech Co., Ltd.
  • 16.26. Xoran Technologies, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPUTED TOMOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL COMPUTED TOMOGRAPHY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL COMPUTED TOMOGRAPHY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL COMPUTED TOMOGRAPHY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MULTI SLICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MULTI SLICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MULTI SLICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 16 SLICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 16 SLICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 16 SLICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 64 SLICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 64 SLICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 64 SLICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ABOVE 64 SLICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABOVE 64 SLICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ABOVE 64 SLICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE SLICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE SLICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE SLICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CALCIUM SCORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CALCIUM SCORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CALCIUM SCORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC STRUCTURE ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC STRUCTURE ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC STRUCTURE ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY CT ANGIOGRAPHY (CTA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY CT ANGIOGRAPHY (CTA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY CT ANGIOGRAPHY (CTA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN PERFUSION STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN PERFUSION STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN PERFUSION STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN TUMOR ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN TUMOR ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN TUMOR ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SKULL FRACTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SKULL FRACTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SKULL FRACTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STROKE EVALUATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STROKE EVALUATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STROKE EVALUATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOPSY GUIDANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPSY GUIDANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOPSY GUIDANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TREATMENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TREATMENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TREATMENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TUMOR DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TUMOR DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TUMOR DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ORTHOPEDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ORTHOPEDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ORTHOPEDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 212. NATO COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 216. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 297. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 307. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 316. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 317. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 336. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 337. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 338. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 340. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 341. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 342. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 346. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 347. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 348. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 349. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 350. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 351. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 353. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 356. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 357. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 358. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 359. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 360. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 361. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 362. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 363. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 364. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2018-2032 (USD MILLION)
  • TABLE 366. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 367. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 368. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 369. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 370. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 371. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 372. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)